| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8819848 | Respiratory Medicine | 2018 | 27 Pages |
Abstract
These results illustrate the cross-sectional and longitudinal effects of excluding FEV1 from GOLD 2017, and highlight both the clinical relevance of symptom assessment in the management of COPD and the prognostic capacity of FEV1.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Rosa Faner, Guillaume Noell, Joan Ramon Badia, Alejandra López-Giraldo, Per Bakke, Edwin K. Silverman, Ruth Tal-Singer, Alvar AgustÃ,